We demonstrated that that when breast cancer cells had been treated with different doses of embelin for 48 h, Bax and Bcl-2 migrated, the mitochondrial membrane potential increase expression of Bax, while Bcl-2 expression decreased and cytochrome C was released. Here, CYCS is linked to breast carcinoma.